Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 06
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Agilon Health Inc
AGL
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$85.41
1.13
1.34%
Últ. Act.: Oct 6, 12:46 PM
$84.28
N/A
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Agilon Health Financials
Agilon Health (AGL) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
CORRECTION: Agilon Health Sees Q3 Sales $1.445B-$1.475B vs $1.415B Est
Agilon Health (NYSE:AGL) sees Q3 sales of $1.445 billion-$1.475 billion vs $1.415 billion analyst estimate.
Benzinga Newsdesk
PRO
CORRECTION: Agilon Health Raises FY2026 Sales Guidance from $5.680B-$5.805B to $5.775B-$5.860B vs $5.719B Est
Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.680 billion-$5.805 billion to $5.775 billion-$5.860 billion vs $5.719 billion estimate.
Benzinga Newsdesk
PRO
Agilon Health Q2 EPS $1.04 Beats $(0.75) Estimate, Sales $1.495B Beat $1.450B Estimate
Agilon Health (NYSE:AGL) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $(0.75) by 238.67 percent. This is a 116.64 percent increase over losses of $(6.25) per share from the
Benzinga Newsdesk
Dow Tumbles Over 300 Points: Investor Sentiment Declines, Fear Index Remains In 'Greed' Zone
The CNN Money Fear and Greed index declined but remained in the Greed zone on Thursday. US stocks fell, some reported higher earnings.
Avi Kapoor
Agilon Health Operational Initiatives Begin Showing Results
Agilon Health shares surge after Q1 earnings beat, raised 2026 outlook, and stronger medical margins offset membership declines.
Vandana Singh
PRO
Agilon Health Raises FY2026 Sales Guidance from $5.410B-$5.580B to $5.680B-$5.805B vs $5.452B Est
Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.410 billion-$5.580 billion to $5.680 billion-$5.805 billion vs $5.452 billion estimate.
Benzinga Newsdesk
